Published in
Elsevier, The Lancet Oncology, 5(16), p. 522-530, 2015
DOI: 10.1016/s1470-2045(15)70122-1
Links
Tools
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): A randomised, double-blind, phase 3 trial
Journal article published in 2015 by
Alexander M. M. Eggermont,
Vanna Chiarion-Sileni 
,
Jean-Jacques Grob,
Reinhard Dummer,
Jedd D. Wolchok,
Henrik Schmidt,
Omid Hamid,
Caroline Robert,
Prof Paolo A. Ascierto,
Jon M. Richards,
Céleste Lebbé,
Virginia Ferraresi,
Michael Smylie,
Jeffrey S. Weber ,
Michele Maio
and other authors.
,
Jean-Jacques Grob,
Reinhard Dummer,
Jedd D. Wolchok,
Henrik Schmidt,
Omid Hamid,
Caroline Robert,
Prof Paolo A. Ascierto,
Jon M. Richards,
Céleste Lebbé,
Virginia Ferraresi,
Michael Smylie,
Jeffrey S. Weber ,
Michele Maio
and other authors.
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 